Skip to Content

  • Search

View Additional Section Content

IMPROVE IT - A Multicenter, Double-Blind, Randomized Study to Establish the clinical Benefit and safety of Vytorin (Ezetimibe/Simvastatin Tablet) vs Simvastatin Monotherapy in High-Risk Subjects Presenting With Acute Coronary Syndrome (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)

Principal Investigator(s)
John H. Wertheimer, M.D.

Clinical Trial Categories

  • Cardiology
Paula Nice at 215-884-4700


  • Pennsylvania Heart and Vascular Group, PC

Find a Physician
Search Our Directory


Schedule a Test
Request an Appointment


Clinical Trials Details